APP and Alzheimer disease: Moreover, Xing’s lab proposed that tPBM (633 nm) shifted the amyloid precursor protein (APP) processing toward the nonamyloidogenic pathway by activating Sirtuin 1 via the cyclic adenosine monophosphate/protein kinase pathway, thereby improving memory and cognitive ability in an AD mouse model.80